Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
clinical hold
clinical study
combination
commissioner
congress
crispr
crispr-cas9
delisting
1
×
democrats
departure
detroit blog main
1
×
detroit top stories
drug pricing
editas medicine
eli lilly
ethics
failure
1
×
fda
furlough
gene editing
1
×
genetic alliance
genome editing
glaxosmithkline
government
he jiankui
house
What
big
1
×
bio
bosley's
bosley’s
bridge
bucks
cas
ceo
crime
crispr
departure
editas
exit
guiding
katrine
medicine
moves
personnel
roundup
surprising
week
Language
Current search:
delisting
×
failure
×
" detroit blog main "
×
big
×
" gene editing "
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More